The Global Autism Spectrum Disorder Therapeutics Market size was valued at USD 3.5 billion in 2018 and is anticipated to grow at a CAGR of 4.9% during the forecast period. Autism spectrum disorder is defined as a group of neurological disorders that are characterized by the persistence deficits in social interaction and social communication accompanied by a repetitive as a restricted pattern of behavior or activities.